Donor sex, age and ethnicity impact stored red blood cell antioxidant metabolism through mechanisms in part explained by glucose 6-phosphate dehydrogenase levels and activity

Red blood cell storage in the blood bank promotes the progressive accumulation of metabolic alterations that may ultimately impact the erythrocyte capacity to cope with oxidant stressors. However, the metabolic underpinnings of the capacity of RBCs to resist oxidant stress and the potential impact o...

Full description

Saved in:
Bibliographic Details
Published in:Haematologica (Roma) Vol. 106; no. 5; pp. 1290 - 1302
Main Authors: D'Alessandro, Angelo, Fu, Xiaoyun, Kanias, Tamir, Reisz, Julie A, Culp-Hill, Rachel, Guo, Yuelong, Gladwin, Mark T, Page, Grier, Kleinman, Steven, Lanteri, Marion, Stone, Mars, Busch, Michael P, Zimring, James C
Format: Journal Article
Language:English
Published: Italy Fondazione Ferrata Storti 01.05.2021
Ferrata Storti Foundation
Subjects:
ISSN:0390-6078, 1592-8721, 1592-8721
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Abstract Red blood cell storage in the blood bank promotes the progressive accumulation of metabolic alterations that may ultimately impact the erythrocyte capacity to cope with oxidant stressors. However, the metabolic underpinnings of the capacity of RBCs to resist oxidant stress and the potential impact of donor biology on this phenotype are not known. Within the framework of the REDS-III RBC-Omics study, RBCs from 8,502 healthy blood donors were stored for 42 days and tested for their propensity to hemolyze following oxidant stress. A subset of extreme hemolyzers donated a second unit of blood, which was stored for 10, 23, and 42 days and profiled again for oxidative hemolysis and metabolomics (599 samples). Alterations of RBC energy and redox homeostasis were noted in donors with high oxidative hemolysis. RBCs from females, donors over 60 years old, donors of Asian/South Asian race-ethnicity, and RBCs stored in additive solution-3 were each independently characterized by improved antioxidant metabolism compared to, respectively, males, donors under 30 years old, Hispanic and African American race ethnicity donors, and RBCs stored in additive solution-1. Merging metabolomics data with results from an independent GWAS study on the same cohort, we identified metabolic markers of hemolysis and G6PD-deficiency, which were associated with extremes in oxidative hemolysis and dysregulation in NADPH and glutathione-dependent detoxification pathways of oxidized lipids. Donor sex, age, ethnicity, additive solution and G6PD status impact the metabolism of the stored erythrocyte and its susceptibility to hemolysis following oxidative insults.
AbstractList Red blood cell storage in the blood bank promotes the progressive accumulation of metabolic alterations that may ultimately impact the erythrocyte capacity to cope with oxidant stressors. However, the metabolic underpinnings of the capacity of RBCs to resist oxidant stress and the potential impact of donor biology on this phenotype are not known. Within the framework of the REDS-III RBC-Omics study, RBCs from 8,502 healthy blood donors were stored for 42 days and tested for their propensity to hemolyze following oxidant stress. A subset of extreme hemolyzers donated a second unit of blood, which was stored for 10, 23, and 42 days and profiled again for oxidative hemolysis and metabolomics (599 samples). Alterations of RBC energy and redox homeostasis were noted in donors with high oxidative hemolysis. RBCs from females, donors over 60 years old, donors of Asian/South Asian race-ethnicity, and RBCs stored in additive solution-3 were each independently characterized by improved antioxidant metabolism compared to, respectively, males, donors under 30 years old, Hispanic and African American race ethnicity donors, and RBCs stored in additive solution-1. Merging metabolomics data with results from an independent GWAS study on the same cohort, we identified metabolic markers of hemolysis and G6PD-deficiency, which were associated with extremes in oxidative hemolysis and dysregulation in NADPH and glutathione-dependent detoxification pathways of oxidized lipids. Donor sex, age, ethnicity, additive solution and G6PD status impact the metabolism of the stored erythrocyte and its susceptibility to hemolysis following oxidative insults.
Red blood cell storage in the blood bank promotes the progressive accumulation of metabolic alterations that may ultimately impact the erythrocyte capacity to cope with oxidant stressors. However, the metabolic underpinnings of the capacity of RBCs to resist oxidant stress and the potential impact of donor biology on this phenotype are not known. Within the framework of the REDS-III RBC-Omics study, RBCs from 8,502 healthy blood donors were stored for 42 days and tested for their propensity to hemolyze following oxidant stress. A subset of extreme hemolyzers donated a second unit of blood, which was stored for 10, 23, and 42 days and profiled again for oxidative hemolysis and metabolomics (599 samples). Alterations of RBC energy and redox homeostasis were noted in donors with high oxidative hemolysis. RBCs from females, donors over 60 years old, donors of Asian/South Asian race-ethnicity, and RBCs stored in additive solution-3 were each independently characterized by improved antioxidant metabolism compared to, respectively, males, donors under 30 years old, Hispanic and African American race ethnicity donors, and RBCs stored in additive solution-1. Merging metabolomics data with results from an independent GWAS study on the same cohort, we identified metabolic markers of hemolysis and G6PD-deficiency, which were associated with extremes in oxidative hemolysis and dysregulation in NADPH and glutathione-dependent detoxification pathways of oxidized lipids. Donor sex, age, ethnicity, additive solution and G6PD status impact the metabolism of the stored erythrocyte and its susceptibility to hemolysis following oxidative insults.Red blood cell storage in the blood bank promotes the progressive accumulation of metabolic alterations that may ultimately impact the erythrocyte capacity to cope with oxidant stressors. However, the metabolic underpinnings of the capacity of RBCs to resist oxidant stress and the potential impact of donor biology on this phenotype are not known. Within the framework of the REDS-III RBC-Omics study, RBCs from 8,502 healthy blood donors were stored for 42 days and tested for their propensity to hemolyze following oxidant stress. A subset of extreme hemolyzers donated a second unit of blood, which was stored for 10, 23, and 42 days and profiled again for oxidative hemolysis and metabolomics (599 samples). Alterations of RBC energy and redox homeostasis were noted in donors with high oxidative hemolysis. RBCs from females, donors over 60 years old, donors of Asian/South Asian race-ethnicity, and RBCs stored in additive solution-3 were each independently characterized by improved antioxidant metabolism compared to, respectively, males, donors under 30 years old, Hispanic and African American race ethnicity donors, and RBCs stored in additive solution-1. Merging metabolomics data with results from an independent GWAS study on the same cohort, we identified metabolic markers of hemolysis and G6PD-deficiency, which were associated with extremes in oxidative hemolysis and dysregulation in NADPH and glutathione-dependent detoxification pathways of oxidized lipids. Donor sex, age, ethnicity, additive solution and G6PD status impact the metabolism of the stored erythrocyte and its susceptibility to hemolysis following oxidative insults.
Red blood cell (RBC) storage in the blood bank promotes the progressive accumulation of metabolic alterations that may ultimately impact the erythrocyte capacity to cope with oxidant stressors. However, the metabolic underpinnings of the capacity of RBC to resist oxidant stress and the potential impact of donor biology on this phenotype are not known. Within the framework of the REDS-III RBC-Omics study, RBC from 8,502 healthy blood donors were stored for 42 days and tested for their propensity to hemolyse following oxidant stress. A subset of extreme hemolysers donated a second unit of blood, which was stored for 10, 23, and 42 days and profiled again for oxidative hemolysis and metabolomics (599 samples). Alterations of RBC energy and redox homeostasis were noted in donors with high oxidative hemolysis. RBC from females, donors over 60 years old, donors of Asian/South Asian race-ethnicity, and RBC stored in additive solution- 3 were each independently characterized by improved antioxidant metabolism compared to, respectively, males, donors under 30 years old, Hispanic and African American race ethnicity donors, and RBC stored in additive solution-1. Merging metabolomics data with results from an independent genome-wide association study on the same cohort, we identified metabolic markers of hemolysis and glucose 6-phosphate dehydrogenasedeficiency, which were associated with extremes in oxidative hemolysis and dysregulation in nicotinamide adenine dinucleotide phosphate and glutathione- dependent detoxification pathways of oxidized lipids. Donor sex, age, ethnicity, additive solution and glucose 6-phosphate dehydrogenase status impact the metabolism of the stored erythrocyte and its susceptibility to hemolysis following oxidative insults.
Author Mars Stone
Angelo D'Alessandro
Tamir Kanias
Marion Lanteri
Steven Kleinman
and Donor Evaluation Study-III (REDS III), For the Recipient Epidemiology
Xiaoyun Fu
Mark T. Gladwin
Julie A. Reisz
Yuelong Guo
Rachel Culp-Hill
James C. Zimring
Grier Page
Michael P. Busch
AuthorAffiliation 7 University of British Columbia , Victoria, Canada
5 University of Pittsburgh , Pittsburgh, PA, USA
8 Vitalant Research Institute (previously Blood Systems Research Institute) , San Francisco, CA, USA
2 Department of Medicine – Division of Hematology, University of Colorado Denver – Anschutz Medical Campus , Aurora, CO, USA
3 Vitalant Research Institute (previously Blood Systems Research Institute), Denver, CO, USA
1 Department of Biochemistry and Molecular Genetics, University of Colorado Denver – Anschutz Medical Campus , Aurora, CO, USA
4 Bloodworks Northwest Research Institute , Seattle, WA, USA
6 RTI International , Atlanta, GA, USA
9 University of Virginia , Charlotesville, VA, USA
AuthorAffiliation_xml – name: 3 Vitalant Research Institute (previously Blood Systems Research Institute), Denver, CO, USA
– name: 1 Department of Biochemistry and Molecular Genetics, University of Colorado Denver – Anschutz Medical Campus , Aurora, CO, USA
– name: 2 Department of Medicine – Division of Hematology, University of Colorado Denver – Anschutz Medical Campus , Aurora, CO, USA
– name: 8 Vitalant Research Institute (previously Blood Systems Research Institute) , San Francisco, CA, USA
– name: 5 University of Pittsburgh , Pittsburgh, PA, USA
– name: 9 University of Virginia , Charlotesville, VA, USA
– name: 6 RTI International , Atlanta, GA, USA
– name: 7 University of British Columbia , Victoria, Canada
– name: 4 Bloodworks Northwest Research Institute , Seattle, WA, USA
Author_xml – sequence: 1
  givenname: Angelo
  surname: D'Alessandro
  fullname: D'Alessandro, Angelo
  organization: University of Colorado Denver, Anschutz Medical Campus, Aurora, CO, USA
– sequence: 2
  givenname: Xiaoyun
  surname: Fu
  fullname: Fu, Xiaoyun
  organization: Bloodworks Northwest Research Institute, Seattle, WA, USA
– sequence: 3
  givenname: Tamir
  surname: Kanias
  fullname: Kanias, Tamir
  organization: Vitalant Research Institute, Denver, CO, USA
– sequence: 4
  givenname: Julie A
  surname: Reisz
  fullname: Reisz, Julie A
  organization: University of Colorado Denver, Anschutz Medical Campus, Aurora, CO, USA
– sequence: 5
  givenname: Rachel
  surname: Culp-Hill
  fullname: Culp-Hill, Rachel
  organization: University of Colorado Denver, Anschutz Medical Campus, Aurora, CO, USA
– sequence: 6
  givenname: Yuelong
  surname: Guo
  fullname: Guo, Yuelong
  organization: RTI International, Atlanta, GA, USA
– sequence: 7
  givenname: Mark T
  surname: Gladwin
  fullname: Gladwin, Mark T
  organization: University of Pittsburgh Medical Center, Pittsburgh PA, USA
– sequence: 8
  givenname: Grier
  surname: Page
  fullname: Page, Grier
  organization: RTI International, Atlanta, GA, USA
– sequence: 9
  givenname: Steven
  surname: Kleinman
  fullname: Kleinman, Steven
  organization: University of British Columbia, Victoria, Canada
– sequence: 10
  givenname: Marion
  surname: Lanteri
  fullname: Lanteri, Marion
  organization: Vitalant Research Institute, San Francisco, CA, USA
– sequence: 11
  givenname: Mars
  surname: Stone
  fullname: Stone, Mars
  organization: Vitalant Research Institute, San Francisco, CA, USA
– sequence: 12
  givenname: Michael P
  surname: Busch
  fullname: Busch, Michael P
  organization: Vitalant Research Institute, San Francisco, CA, USA
– sequence: 13
  givenname: James C
  surname: Zimring
  fullname: Zimring, James C
  organization: University of Virginia, Charlottesville, VA, USA
BackLink https://www.ncbi.nlm.nih.gov/pubmed/32241843$$D View this record in MEDLINE/PubMed
BookMark eNp9kk1r3DAQhk1JaT7af1CKjj3UW1mSbamHQki_AoFe2rMYW2NbQbZcS7vs_qn-xsrZJDQ9FCQEM-88M2Le8-xk8hNm2euCbjhn4v0AOEL0bsMooxsmqoryZ9lZUSqWy5oVJ9kZ5YrmFa3laXYewi1NQqXqF9kpZ0wUUvCz7PcnP_mFBNy_I9AjgckQjMNkWxsPxI4ztJGE6Bc0ZL2N896QFp1L0mj93pr0khEjNN7ZMJI4LH7bDynUDjClSCB2IjMskeB-dmCnFXMgvdu2PiCp8nnwYR4gIjE4HMzie5wgZRzu0IW7kdIUdpcmepk978AFfHX_XmQ_v3z-cfUtv_n-9frq8iZvRS1iDk1hyrqtTWOwEB0UkqFApkrAppGdakpRokmHAy2KOqUEKiwa5BRaRpFfZNdHrvFwq-fFjrActAer7wJ-6XX6kG0dapkQsuaGCzACVCmV7EpVFlVnVE2bJrE-HlnzthnRtDjFBdwT6NPMZAfd-52WVAmqygR4ew9Y_K8thqhHG9YVwIR-GzTjsmK1FKpK0jd_93ps8rDwJBBHQbv4EBbsHiUF1auv9IOv9OorffRVKvvwT1nyB6T9rxNb9__iP7t93D0
CitedBy_id crossref_primary_10_3389_fphys_2021_639722
crossref_primary_10_1182_blood_2024024679
crossref_primary_10_1016_j_transci_2020_103019
crossref_primary_10_1111_apha_14081
crossref_primary_10_1111_jvim_17015
crossref_primary_10_1111_trf_18019
crossref_primary_10_1182_blood_2022017288
crossref_primary_10_1111_trf_16558
crossref_primary_10_3389_fphys_2022_828087
crossref_primary_10_1111_trf_16395
crossref_primary_10_3390_ijms232213815
crossref_primary_10_1016_j_clp_2023_07_008
crossref_primary_10_3389_fphys_2022_845347
crossref_primary_10_3390_cells10092293
crossref_primary_10_1371_journal_pone_0259267
crossref_primary_10_26565_2313_6693_2025_54_11
crossref_primary_10_3389_fphys_2022_953257
crossref_primary_10_1371_journal_pone_0269619
crossref_primary_10_1111_acel_13798
crossref_primary_10_1021_acsomega_5c01888
crossref_primary_10_3389_fphys_2023_1151268
crossref_primary_10_1007_s12035_022_02980_7
crossref_primary_10_1159_000530870
crossref_primary_10_1016_j_transci_2023_103827
crossref_primary_10_1016_j_transci_2024_104016
crossref_primary_10_1182_bloodadvances_2021005975
crossref_primary_10_1111_trf_17756
crossref_primary_10_1182_bloodadvances_2024015257
crossref_primary_10_3389_fphys_2022_868578
crossref_primary_10_1016_j_transci_2024_104011
crossref_primary_10_1111_bjh_18287
crossref_primary_10_1111_trf_16869
crossref_primary_10_3389_fphys_2023_1303815
crossref_primary_10_2337_db23_0355
crossref_primary_10_1016_j_bcmd_2025_102935
crossref_primary_10_1111_trf_17472
crossref_primary_10_1111_trf_18286
crossref_primary_10_3390_ijms22020896
crossref_primary_10_1111_trf_16141
crossref_primary_10_1111_trf_17471
crossref_primary_10_1097_PCC_0000000000002859
crossref_primary_10_3389_fphys_2022_916197
crossref_primary_10_1016_j_tmrv_2023_150750
crossref_primary_10_1038_s41598_022_26309_5
crossref_primary_10_1182_blood_2023022052
crossref_primary_10_1002_ansa_202200039
crossref_primary_10_1371_journal_pcbi_1012109
crossref_primary_10_1021_acs_jproteome_5c00166
crossref_primary_10_1111_trf_16815
crossref_primary_10_1172_JCI183099
crossref_primary_10_1182_bloodadvances_2024014475
crossref_primary_10_1016_j_tracli_2021_08_344
crossref_primary_10_1093_procel_pwae001
crossref_primary_10_1097_MOH_0000000000000863
crossref_primary_10_1111_trf_16851
crossref_primary_10_1038_s41586_020_03129_z
crossref_primary_10_1111_trf_16017
crossref_primary_10_1111_trf_17749
crossref_primary_10_1182_bloodadvances_2022006987
crossref_primary_10_1111_jvim_17031
crossref_primary_10_3389_fphys_2024_1427094
crossref_primary_10_3390_ijms22073369
crossref_primary_10_1152_japplphysiol_00629_2024
crossref_primary_10_1038_s41598_025_90760_3
crossref_primary_10_1124_jpet_123_001634
crossref_primary_10_1007_s00277_022_04907_7
crossref_primary_10_7554_eLife_81316
crossref_primary_10_1016_j_tmrv_2023_03_001
crossref_primary_10_1182_blood_2024026109
crossref_primary_10_3390_biom13081262
crossref_primary_10_1182_bloodadvances_2022008061
crossref_primary_10_1111_trf_16402
crossref_primary_10_1016_j_clim_2025_110512
crossref_primary_10_1172_JCI146077
crossref_primary_10_2147_JBM_S397139
crossref_primary_10_3389_fphys_2021_735543
crossref_primary_10_1111_trf_17857
crossref_primary_10_3390_separations8090142
crossref_primary_10_1111_trf_17492
crossref_primary_10_1182_bloodadvances_2022008936
crossref_primary_10_1111_trf_16168
crossref_primary_10_1016_j_jbc_2022_102706
crossref_primary_10_1016_j_heliyon_2024_e32056
crossref_primary_10_1001_jamanetworkopen_2021_23942
crossref_primary_10_1016_j_ebiom_2024_105498
crossref_primary_10_1111_tme_12871
crossref_primary_10_1073_pnas_2115616120
crossref_primary_10_3389_fphys_2022_833242
crossref_primary_10_3389_fphys_2020_616457
Cites_doi 10.1182/blood-2016-05-714816
10.3109/13813455.2015.1136648
10.1111/vox.12068
10.1111/trf.15339
10.1111/trf.14971
10.1016/j.transci.2010.05.011
10.1097/MOH.0000000000000455
10.1080/14789450.2018.1531710
10.1016/j.freeradbiomed.2016.04.005
10.1016/j.athoracsur.2018.08.073
10.1182/blood-2016-06-721688
10.3324/haematol.2017.178608
10.1080/14789450.2018.1453362
10.1111/trf.12992
10.1111/trf.15012
10.1038/cdd.2017.100
10.1111/trf.13745
10.1111/trf.14620
10.1111/trf.13071
10.1182/bloodadvances.2017004820
10.1111/trf.12804
10.1111/trf.14998
10.1038/ncb3346
10.1111/trf.13363
10.1159/000343123
10.1111/trf.13582
10.1111/trf.15099
10.1111/j.1365-2141.1989.tb06286.x
10.1111/vox.12563
10.1111/trf.14987
10.1172/JCI133530
10.3389/fmed.2017.00248
10.3389/fmed.2018.00164
10.1080/14789450.2019.1571917
10.4269/ajtmh.14-0194
10.1111/trf.14979
10.1111/trf.15133
10.1111/trf.15541
10.1111/trf.13211
10.1111/vox.12378
10.1182/bloodadvances.2019000605
10.1002/ajh.25051
ContentType Journal Article
Copyright Copyright© 2021 Ferrata Storti Foundation
Copyright_xml – notice: Copyright© 2021 Ferrata Storti Foundation
CorporateAuthor Recipient Epidemiology and Donor Evaluation Study-III (REDS III)
CorporateAuthor_xml – name: Recipient Epidemiology and Donor Evaluation Study-III (REDS III)
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
5PM
DOA
DOI 10.3324/haematol.2020.246603
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE
CrossRef
MEDLINE - Academic


Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: 7X8
  name: MEDLINE - Academic
  url: https://search.proquest.com/medline
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Anatomy & Physiology
EISSN 1592-8721
EndPage 1302
ExternalDocumentID oai_doaj_org_article_8a01873d34ad4a95898f59516fd970bb
PMC8094095
32241843
10_3324_haematol_2020_246603
Genre Research Support, Non-U.S. Gov't
Journal Article
Research Support, N.I.H., Extramural
GrantInformation_xml – fundername: NIH HHS
  grantid: S10 OD021641
– fundername: NHLBI NIH HHS
  grantid: HHSN268201100002I
– fundername: WHI NIH HHS
  grantid: HHSN268201100001C
– fundername: NHLBI NIH HHS
  grantid: HHSN268201100004I
– fundername: NIGMS NIH HHS
  grantid: RM1 GM131968
– fundername: NHLBI NIH HHS
  grantid: HHSN268201100008I
– fundername: NHLBI NIH HHS
  grantid: R01 HL148151
– fundername: NHLBI NIH HHS
  grantid: R01 HL146442
– fundername: NHLBI NIH HHS
  grantid: HHSN268201100003I
– fundername: NHLBI NIH HHS
  grantid: HHSN268201100005I
GroupedDBID ---
29I
2WC
53G
5GY
5RE
5VS
AAFWJ
AAYXX
ADBBV
AENEX
AFPKN
ALMA_UNASSIGNED_HOLDINGS
AOIJS
BAWUL
BCNDV
BTFSW
CITATION
CS3
DIK
E3Z
EBS
EJD
F5P
FRP
GROUPED_DOAJ
H13
HYE
KQ8
OK1
OVT
P2P
RHI
RNS
RPM
SJN
TFS
TR2
W8F
WOQ
WOW
CGR
CUY
CVF
ECM
EIF
NPM
7X8
5PM
ID FETCH-LOGICAL-c474t-ab1d57c7dbde14fa182e4e295aebb8f9b545ed5ed3a01174e24e9e1be30ac20e3
IEDL.DBID DOA
ISICitedReferencesCount 115
ISICitedReferencesURI http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000646903300010&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN 0390-6078
1592-8721
IngestDate Fri Oct 03 12:44:29 EDT 2025
Thu Aug 21 13:58:56 EDT 2025
Sun Nov 09 13:18:28 EST 2025
Mon Jul 21 05:56:13 EDT 2025
Sat Nov 29 06:32:56 EST 2025
Tue Nov 18 22:27:33 EST 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 5
Language English
License https://creativecommons.org/licenses/by-nc/4.0/legalcode
This article is distributed under the terms of the Creative Commons Attribution Noncommercial License (by-nc 4.0) which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c474t-ab1d57c7dbde14fa182e4e295aebb8f9b545ed5ed3a01174e24e9e1be30ac20e3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
RBC-Omics study group members
Disclosures
Though unrelated to the contents of this manuscripts, the authors declare that AD is a founder of Omix Technologies Inc and Altis Biosciencens LLC. James C Zimring serves as a consultant for Rubius Therapeutics. All the other authors disclose no conflicts of interest relevant to this study. Angelo D’Alessandro is a consultant for Hemanext Inc. James C Zimring serves on the scientific advisory board for Rubius Therapeutics. All the other authors disclose no conflicts of interest relevant to this study.
Contributions
TK, SK, MTG, ML, MS, MPB, GP, JCZ designed the study. AD, XF, JAR, RCH, JCZ performed metabolomics analyses; YG, GP performed genomics analyses; TK performed oxidative hemolysis measurements; AD prepared figures and wrote the first version of the manuscript. All the authors contributed to the finalization of the manuscript.
The NHLBI Recipient Epidemiology Donor Evaluation Study- III (REDS-III), Red Blood Cell (RBC)-Omics study, is the responsibility of the following persons: Hubs: AE Mast, JL Gottschall, WB, LA, JM, AH, ZU, and VJ, BloodCenter of Wisconsin, Milwaukee, WI, USA; DJT, JEK and PAD’A, The Institute for Transfusion Medicine (ITXM), Pittsburgh, PA, USA; E. L. Murphy and AMG, University of California, San Francisco, San Francisco, CA, USA; RGC, BRS, and STJ; American Red Cross Blood Services, Farmington, CT, USA; Data coordinating center: DJB, MTS, SME, GPP, YG, NH, DR, and BCS; RTI International, Rockville, MD, USA; Central and testing laboratories: MPB, MCL, MS, and SK, Blood Systems Research Institute, San Francisco, CA, USA; TK and MG, Pittsburgh Heart, Lung, Blood, and Vascular Medicine Institute, Division of Pulmonary, Allergy and Critical Care Medicine, University of Pittsburgh, Pittsburgh, PA, USA; Steering committee chairman: SHK, University of British Columbia, Victoria, BC, Canada; National Heart, Lung, and Blood Institute, National Institutes of Health: SAG, KBM and AMC.
OpenAccessLink https://doaj.org/article/8a01873d34ad4a95898f59516fd970bb
PMID 32241843
PQID 2386278496
PQPubID 23479
PageCount 13
ParticipantIDs doaj_primary_oai_doaj_org_article_8a01873d34ad4a95898f59516fd970bb
pubmedcentral_primary_oai_pubmedcentral_nih_gov_8094095
proquest_miscellaneous_2386278496
pubmed_primary_32241843
crossref_primary_10_3324_haematol_2020_246603
crossref_citationtrail_10_3324_haematol_2020_246603
PublicationCentury 2000
PublicationDate 2021-05-01
PublicationDateYYYYMMDD 2021-05-01
PublicationDate_xml – month: 05
  year: 2021
  text: 2021-05-01
  day: 01
PublicationDecade 2020
PublicationPlace Italy
PublicationPlace_xml – name: Italy
PublicationTitle Haematologica (Roma)
PublicationTitleAlternate Haematologica
PublicationYear 2021
Publisher Fondazione Ferrata Storti
Ferrata Storti Foundation
Publisher_xml – name: Fondazione Ferrata Storti
– name: Ferrata Storti Foundation
References 25543
25542
25545
25544
25547
25546
25549
25548
25541
25540
25518
25517
25519
25510
25554
25553
25512
25556
25511
25555
25514
25558
25513
25557
25516
25515
25559
25550
25552
25551
25529
25528
25521
25520
25523
25522
25525
25524
25527
25526
25539
25532
25531
25534
25533
25536
25535
25538
25537
25530
References_xml – ident: 25512
– ident: 25531
  doi: 10.1182/blood-2016-05-714816
– ident: 25553
  doi: 10.3109/13813455.2015.1136648
– ident: 25535
  doi: 10.1111/vox.12068
– ident: 25558
  doi: 10.1111/trf.15339
– ident: 25543
  doi: 10.1111/trf.14971
– ident: 25518
  doi: 10.1016/j.transci.2010.05.011
– ident: 25549
  doi: 10.1097/MOH.0000000000000455
– ident: 25559
  doi: 10.1080/14789450.2018.1531710
– ident: 25537
  doi: 10.1016/j.freeradbiomed.2016.04.005
– ident: 25527
  doi: 10.1016/j.athoracsur.2018.08.073
– ident: 25515
  doi: 10.1182/blood-2016-06-721688
– ident: 25522
  doi: 10.3324/haematol.2017.178608
– ident: 25530
– ident: 25548
  doi: 10.1080/14789450.2018.1453362
– ident: 25521
  doi: 10.1111/trf.12992
– ident: 25550
  doi: 10.1111/trf.15012
– ident: 25554
  doi: 10.1038/cdd.2017.100
– ident: 25541
  doi: 10.1111/trf.13745
– ident: 25520
  doi: 10.1111/trf.14620
– ident: 25516
  doi: 10.1111/trf.13071
– ident: 25546
  doi: 10.1182/bloodadvances.2017004820
– ident: 25540
– ident: 25510
  doi: 10.1111/trf.12804
– ident: 25556
  doi: 10.1111/trf.14998
– ident: 25557
  doi: 10.1038/ncb3346
– ident: 25532
  doi: 10.1111/trf.13363
– ident: 25552
  doi: 10.1159/000343123
– ident: 25542
  doi: 10.1182/bloodadvances.2017004820
– ident: 25534
  doi: 10.1111/trf.13582
– ident: 25547
  doi: 10.1111/trf.15099
– ident: 25519
  doi: 10.1111/j.1365-2141.1989.tb06286.x
– ident: 25514
– ident: 25517
– ident: 25528
  doi: 10.1111/vox.12563
– ident: 25544
  doi: 10.1111/trf.14987
– ident: 25539
  doi: 10.1172/JCI133530
– ident: 25524
– ident: 25536
  doi: 10.3389/fmed.2017.00248
– ident: 25513
  doi: 10.3389/fmed.2018.00164
– ident: 25526
  doi: 10.1080/14789450.2019.1571917
– ident: 25551
  doi: 10.4269/ajtmh.14-0194
– ident: 25545
  doi: 10.1111/trf.14979
– ident: 25555
  doi: 10.1111/trf.15133
– ident: 25511
– ident: 25525
  doi: 10.1111/trf.15541
– ident: 25533
  doi: 10.1111/trf.13211
– ident: 25529
  doi: 10.1111/vox.12378
– ident: 25523
  doi: 10.1182/bloodadvances.2019000605
– ident: 25538
  doi: 10.1002/ajh.25051
SSID ssj0020997
Score 2.6242232
Snippet Red blood cell storage in the blood bank promotes the progressive accumulation of metabolic alterations that may ultimately impact the erythrocyte capacity to...
Red blood cell (RBC) storage in the blood bank promotes the progressive accumulation of metabolic alterations that may ultimately impact the erythrocyte...
SourceID doaj
pubmedcentral
proquest
pubmed
crossref
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
StartPage 1290
SubjectTerms Adult
Antioxidants
Blood Preservation
Erythrocytes
Ethnicity
Female
Glucose
Glucosephosphate Dehydrogenase - genetics
Hemolysis
Humans
Male
Middle Aged
Phosphates
Title Donor sex, age and ethnicity impact stored red blood cell antioxidant metabolism through mechanisms in part explained by glucose 6-phosphate dehydrogenase levels and activity
URI https://www.ncbi.nlm.nih.gov/pubmed/32241843
https://www.proquest.com/docview/2386278496
https://pubmed.ncbi.nlm.nih.gov/PMC8094095
https://doaj.org/article/8a01873d34ad4a95898f59516fd970bb
Volume 106
WOSCitedRecordID wos000646903300010&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVAON
  databaseName: DOAJ Directory of Open Access Journals
  customDbUrl:
  eissn: 1592-8721
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0020997
  issn: 0390-6078
  databaseCode: DOA
  dateStart: 19940101
  isFulltext: true
  titleUrlDefault: https://www.doaj.org/
  providerName: Directory of Open Access Journals
link http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3di9QwEA96iPgieufHnnpEEJ-s14-0SR7Pj8MXDx8U9q2kzZQWdtOy7cnuP-XfeDNpu9yKcC9CPyBJk6EzTWaamd8w9k6kssxiAwHOA2Sg4EVVaLiaNLLWlCWYsPLJJuTVlVou9Y9bqb7IJ2yEBx5f3LkylDYusYkwVhidKq2qFNWCrLJahkVBs28o9WxMTaYWxYP6_QONxhGugmPQXILaw3ltCAy1pW2HOPwYiyybE2ZNi5LH7v-Xwvm33-SthejyCXs8aZD8YqT8KbsH7pidXDgcbb3j77n36fQ_y4_Zw-_T1vkJ-_Olde2G97D9wHEO4cZZDkPtsHrY8TFYkpOrJFhOp_do5_RfH5si97aNxTtfw4Bis2r6NZ9S_GARRQ9jSc8bxzt8pRy23crgsNjNjk9e8TwLurrtuxq1W26h3tlNi9KLqyhfkedS70miOAtKZ_GM_br8-vPzt2BK1hCUQoohMEVkke_SFhYiURm0W0BArFMDRaEqXaCqBhaPxBAMHVYJ0BAVkISEEgnJc3bkWgcvGY6EZnkmykhW2FOhjUirKAMKfpdVEqsFS2Zu5eWEZE4JNVY5WjTE43zmcU48zkceL1iwf6obkTzuaP-JBGHflnC4fQFKZz5JZ36XdC7Y21mMcvxuiWnGQXvd56gqZbTpq7MFezGK1X6ohPQqJZAEeSBwB7Qc1rim9tjgivAQdXr6P4h_xR7F5MHj3Ttfs6Nhcw1v2IPy99D0mzN2Xy7Vmf_sbgAsUTXF
linkProvider Directory of Open Access Journals
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Donor+sex%2C+age+and+ethnicity+impact+stored+red+blood+cell+antioxidant+metabolism+through+mechanisms+in+part+explained+by+glucose+6-phosphate+dehydrogenase+levels+and+activity&rft.jtitle=Haematologica+%28Roma%29&rft.au=Angelo+D%27Alessandro&rft.au=Xiaoyun+Fu&rft.au=Tamir+Kanias&rft.au=Julie+A.+Reisz&rft.date=2021-05-01&rft.pub=Ferrata+Storti+Foundation&rft.issn=0390-6078&rft.eissn=1592-8721&rft.volume=106&rft.issue=5&rft_id=info:doi/10.3324%2Fhaematol.2020.246603&rft.externalDBID=DOA&rft.externalDocID=oai_doaj_org_article_8a01873d34ad4a95898f59516fd970bb
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0390-6078&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0390-6078&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0390-6078&client=summon